Insmed Incorporated (INSM) Investor Relations Documents

Insmed Incorporated (INSM) investor relations documents from the company's IR site: 12 presentations, 16 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

Earnings deck: Insmed Q2 2026 earnings presentation reports $425.5M in total revenue and raises the combined peak revenue estimate for its three lead assets to over $14 billion.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Earnings deckEarnings deck
2026-08-06Press releasePress release
2026-08-06Press releasePress release
2026-08-01PresentationPresentation
2026-07-23Press releaseInsmed Second-Quarter 2026 Financial Results Conference Call
2026-07-16Earnings deckEarnings deck
2026-07-16Press releaseInsmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation
2026-06-23Press releaseInsmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory
2026-06-04Press releaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2026-05-27Press releaseInsmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference
2026-05-07Earnings deckhttps://investor.insmed.com/image/Q1+2026+Earnings+Presentation.pdf
2026-05-07Press releasehttps://investor.insmed.com/image/2026-05-07-Insmed-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.pdf
2026-05-06Press releasehttps://investor.insmed.com/2026-05-06-Insmed-and-Ty-Pennington-Team-Up-to-Drive-Awareness-and-Proper-Diagnosis-of-Bronc
2026-05-04Press releaseInsmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE
2026-05-01PresentationDownload the Investor Presentation
2026-04-30Press releaseInsmed to Present at May 2026 Investor Conferences
2026-04-23Press releaseInsmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
2026-04-07Press releaseInsmed Provides Clinical Update on Phase 2b CEDAR Study
2026-03-24Annual reportDownload 2025 Annual Report
2026-03-23Presentationhttps://investor.insmed.com/image/Insmed+Phase+3+ENCORE+Topline+Readout+vFINAL.pdf
2026-03-23Press releasehttps://investor.insmed.com/download/2026-03-23-Insmed-Announces-Positive-Topline-Results-from-Phase-3b-ENCORE-Study-of-
2026-02-19Press releasehttps://investor.insmed.com/image/2026-02-19-Insmed-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.pdf
2026-02-19Earnings deckhttps://investor.insmed.com/image/Insmed-Q4-2025-Earnings-Presentation.pdf
2026-02-12PresentationPresentation
2025-08-06Earnings deckEarnings deck
2025-03-31Annual reportDownload 2024 Annual Report
2024-11-21PresentationPresentation
2024-10-31Press releasePress release
2024-07-31ESG reportDownload 2023 Responsibility Report
2024-05-28PresentationPresentation
2024-04-01Annual reportDownload 2023 Annual Report
2024-01-05PresentationPresentation
2023-03-30Annual reportDownload 2022 Annual Report

INSM overview · INSM earnings · INSM financials · INSM KPIs · INSM documents · INSM ownership · INSM peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.